Emend IV

fosaprepitant · Eisai

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Emend IV, covering 2015-05-27 to 2025-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Antiemetic Fosaprepitant To Remedy Nausea and Vomiting [Phase 2, Phase 3]